Resources

Sharing knowledge about promising practices and their sustainable implementation is vital to ending the opioid crisis. Our resources include the recommendations of experts and the perspectives of those on the frontlines.

COVID-19

DEA: Narcotic Treatment Programs Exception to 21 CFR 1301.74(i)

March 16, 2020

The Drug Enforcement Administration (DEA) has granted narcotic treatment programs (NTPs) an exception to 21 CFR 1301.74(i) in order to provide consistent dosing to patients enrolled.

arrow-icn

COVID-19

NIDA: Potential Implications for Individuals with Substance Use Disorders

March 12, 2020

Nora Volkow, M.D., Director of the National Institute on Drug Abuse (NIDA), highlights the added risks that populations with substance use disorder face during the COVID-19 pandemic.

arrow-icn